Search

Author/Creator Monte, Marc

1. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma. Issue 10 (October 2014)

Authors:
Dakhil, Shaker; Hermann, Robert; Schreeder, Marshall T.; Gregory, Stephanie A.; Monte, Marc; Windsor, Kevin S.; Hurst, Deborah; Chai, Akiko; Brewster, Michael; Richards, Paul
Journal:
Leukemia & lymphoma
Issue:
Volume 55:Issue 10(2014:Oct.)
Page Start:
2335
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice. (4th November 2015)

Authors:
Richards, Donald; Li, Si G; Anderson, Thomas; Monte, Marc; Ulrich, Brian; Smith, David A; Seetharam, Mahesh; Kaywin, Paul; Page, Ray; Kulig, Kimary; Batenchuk, Cory; Hussein, Maen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice. Issue 2 (December 2015)

Authors:
Richards, Donald; Li, Si; Anderson, Thomas; Monte, Marc; Ulrich, Brian; Smith, David; Seetharam, Mahesh; Kaywin, Paul; Page, Ray; Kulig, Kimary; Batenchuk, Cory; Hussein, Maen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗